Sec Form 3 Filing - A&B (HK) Co Ltd @ HELIUS MEDICAL TECHNOLOGIES, INC. - 2015-12-29

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person A&B (HK) Co Ltd 2. Issuer Name and Ticker or Trading Symbol HELIUS MEDICAL TECHNOLOGIES, INC. [ HSDT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) UNIT A, 11TH FLOOR, CHUNG PONT, COMMERCIAL BUILDING, 300 HENNESSY ROAD 3. Date of Earliest Transaction (MM/DD/YY) 12/29/2015 (Street) WANCHAI, K3 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Common Stock 7,638,889 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Warrant $ 1.44 11/10/2015 11/12/2018 Class A Common Stock 1,041,667 D Warrant $ 1.35 01/07/2016 01/07/2019 Class A Common Stock 2,777,778 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other A&B (HK) Co Ltd UNIT A, 11TH FLOOR, CHUNG PONT COMMERCIAL BUILDING, 300 HENNESSY ROAD WANCHAI, K3 X A&B Brother Ltd TRIDENT CHAMBERS, P.O. BOX 146 ROAD TOWN TORTOLA, VIVG1110 X Lam Kong 8/F BLDG A, TONGFANG INFORMATION HARBOR NO. 11 LANGSHAN ROAD NANSHAN DISTRICT, SHENZHEN, F4 X Signatures A&B (HK) COMPANY LIMITED, By: /s/ Lam Kong, Name: Dr. Lam Kong, Title: Director 03/04/2016 Signature of Reporting Person Date A&B BROTHER LIMITED, By: /s/ Lam Kong, Name: Dr. Lam Kong, Title: Director 03/04/2016 Signature of Reporting Person Date /s/ Lam Kong, Dr. Lam Kong 03/04/2016 Signature of Reporting Person Date

Explanation of Responses:
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.